Find your path to Tony
460 people in our graph share verified history with Tony β schools, employers, funds. One of them is your warm intro.
About
Tony Ho previously served as Executive Vice President and Head of Research and Development at CRISPR Therapeutics, where he built an R&D pipeline that advanced multiple candidates into the clinic, including CTX001 and several allogeneic CAR-T programs. Before that, he held senior roles at AstraZeneca overseeing oncology programs such as Lynparza and Imfinzi, led Neurology and Ophthalmology at Merck, and co-founded Neuronyx as its CSO. He holds a B.S. in Electrical Engineering from UCLA and an M.D. from Johns Hopkins, and holds academic appointments in neurology at the University of Pennsylvania and Johns Hopkins.
Invests in
BiotechHealthtechMedical Devices
Experience
- Pivotal LifesciencesChief Scientific Officer & Senior Science Partnercurrent2022 β presentBoston, Massachusetts, United States
- Self-employedBiotech Entrepreneurcurrent2022 β presentBoston, Massachusetts, United States
- CRISPR TherapeuticsExecutive Vice President and Head of Research and Development2017 β 2021Greater Boston Area
- AstraZenecaHead of Oncology Innovation and Integration, Senior Vice President2012 β 2017Washington D.C. Metro Area
- AstraZenecaGlobal Medicine Leader Imfinzi (Durvalumab/MEDI4736), Vice President Immuno-Oncology2012 β 2017
- AstraZenecaGlobal Product Vice President, Olaparib, Oncology GMED2012 β 2015United States
- AstraZenecaVice President, Clinical Innovative Medicine- New Opportunities2012 β 2013
- Merck & Co., Inc.Neurology & Ophthalmology Section Head/ Executive Director2003 β 2011
- Merck & Co., Inc.Senior Director Clinical Neuroscience and Ophthalmology2007 β 2010
- NeuronyxCo-founder, Chief Scientific Officer, Senior Vice President of R & D2000 β 2003
- Johns Hopkins UniversityAssistant Professor of Neurology1997 β 2000
- Johns Hopkins HospitalNeurology Residency & Fellowship1992 β 1997
- Massachusetts General HospitalInternship1991 β 1992
Skills & more
+12 more
BiotechnologyPharmaceutical IndustryDrug DiscoveryGCPNeuropathic PainStrokeAlzheimer's diseaseGlaucomaDry EyeBusiness DevelopmentOsteoporosisNeurodegenerative DiseaseFrom Tony's professional profile.
Colleagues at Pivotal Life Sciences
Frequently asked questions
- Who is Tony Ho?
- Tony Ho previously served as Executive Vice President and Head of Research and Development at CRISPR Therapeutics, where he built an R&D pipeline that advanced multiple candidates into the clinic, including CTX001 and several allogeneic CAR-T programs. Before that, he held senior roles at AstraZeneca overseeing oncology programs such as Lynparza and Imfinzi, led Neurology and Ophthalmology at Merck, and co-founded Neuronyx as its CSO. He holds a B.S. in Electrical Engineering from UCLA and an M.D. from Johns Hopkins, and holds academic appointments in neurology at the University of Pennsylvania and Johns Hopkins.
- Where does Tony Ho work?
- Tony Ho is at Pivotal Life Sciences.
- What does Tony Ho invest in?
- Tony Ho invests in Biotech, Healthtech, Medical Devices.
- Where did Tony Ho go to school?
- Tony Ho studied at The Johns Hopkins University School of Medicine (M.D., Medicine); UCLA (B. S., Electrical Engineering); Katella High School.
Same school
Also attended The Johns Hopkins University School of Medicine82
+ 76 more
Also attended UCLA1,020
+ 1,014 more
Shared employers
Also worked at CRISPR Therapeutics16
+ 10 more
Also worked at AstraZeneca159
+ 153 more
Also worked at Merck & Co., Inc.262
+ 256 more
Also worked at Johns Hopkins University128
+ 122 more














































